Literature DB >> 30922481

Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.

Muthiah Vaduganathan, Ravi B Patel, Avinainder Singh, Cian P McCarthy, Arman Qamar, James L Januzzi, Benjamin M Scirica, Javed Butler, Christopher P Cannon, Deepak L Bhatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30922481      PMCID： PMC6764415          DOI： 10.1016/j.jacc.2019.01.029

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.

Authors:  Muthiah Vaduganathan; Vasanth Sathiyakumar; Avinainder Singh; Cian P McCarthy; Arman Qamar; James L Januzzi; Benjamin M Scirica; Javed Butler; Christopher P Cannon; Deepak L Bhatt
Journal:  J Am Coll Cardiol       Date:  2018-12-25       Impact factor: 24.094

2.  2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; William T Cefalu; James L Januzzi; Rita Rastogi Kalyani; Mikhail Kosiborod; Melissa L Magwire; Pamela B Morris; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2018-11-26       Impact factor: 24.094

3.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122
  3 in total
  9 in total

1.  Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial.

Authors:  Brahim Redouane; Stephen J Greene; Marat Fudim; Muthiah Vaduganathan; Andrew P Ambrosy; Jie-Lena Sun; Adam D DeVore; Steven E McNulty; Robert J Mentz; Adrian F Hernandez; G Michael Felker; Lauren B Cooper; Barry A Borlaug; Eric J Velazquez; Kenneth B Margulies; Abhinav Sharma
Journal:  Circ Heart Fail       Date:  2020-05-04       Impact factor: 8.790

Review 2.  Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Authors:  Aakash Bavishi; Ravi B Patel
Journal:  Heart Fail Clin       Date:  2020-07-21       Impact factor: 3.179

3.  Implications of Specialist Density for Diabetes Care in the United States.

Authors:  Ravi B Patel; Mahmoud Al Rifai; John W McEvoy; Muthiah Vaduganathan
Journal:  JAMA Cardiol       Date:  2019-11-01       Impact factor: 14.676

Review 4.  Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.

Authors:  Lee-Shing Chang; Muthiah Vaduganathan; Jorge Plutzky; Vanita R Aroda
Journal:  Curr Diab Rep       Date:  2019-12-04       Impact factor: 4.810

Review 5.  Implementation of Cardiometabolic Centers and Training Programs.

Authors:  Mohamad B Taha; Neha Rao; Muthiah Vaduganathan; Miguel Cainzos-Achirica; Khurram Nasir; Kershaw V Patel
Journal:  Curr Diab Rep       Date:  2022-03-22       Impact factor: 4.810

6.  Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013-2018.

Authors:  Chintan V Dave; Sebastian Schneeweiss; Deborah J Wexler; Gregory Brill; Elisabetta Patorno
Journal:  Diabetes Care       Date:  2020-02-10       Impact factor: 19.112

Review 7.  Cardioprotective diabetes drugs: what cardiologists need to know.

Authors:  Jenifer M Brown; Brendan M Everett
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-11-13

8.  National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020.

Authors:  Rishav Adhikari; Kunal Jha; Zeina Dardari; James Heyward; Roger S Blumenthal; Robert H Eckel; G Caleb Alexander; Michael J Blaha
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

9.  Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.

Authors:  Oliver Schnell; Xavier Cos; Francesco Cosentino; Thomas Forst; Francesco Giorgino; Hiddo J L Heersprink; Mikhail Kosiborod; Christoph Wanner; Eberhard Standl
Journal:  Cardiovasc Diabetol       Date:  2021-03-31       Impact factor: 9.951
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.